Vpriv Injection, Powder, Lyophilized, For Solution
Product Images NDC 54092-701

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vpriv (NDC 54092-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vpriv 01

This is a description of VPRIV (velaglucerase alfa), an injectable medication used for intravenous use only. Following reconstitution with Sterile Water for Injection, USP, the resultant concentration s 100 units/mL. It must be refrigerated, stored at 2ºC to 8ºC. Each single-dose vial contains 400 units of velaglucerase alfa and other ingredients. VPRIV is made by Takeda Pharmaceuticals and is a registered trademark of Shire Human Genetic Therapies, Inc. Dosage instructions are available in the prescribing information. Contact 1-800-828-2088 for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.